JNM CE/SAM (April 2018): The Utility of PET/CT in the Planning of External Radiation Therapy for Prostate Cancer

JNM, August 2018, Volume 59, Number 4

Release Date: 4/1/2018
Expiration Date: 4/30/2021

SNMMI Members: Free
Non-Members: $69.00

Continuing Education Credit Information

ABNM SAM Credit
The American Board of Nuclear Medicine has reviewed and approved this Journal SAM activity submitted by the SNMMI. This activity fulfills the requirements of the ABNM Maintenance of Certification program for self-assessment. 2.0 SAMs have been awarded for this activity.

AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SNMMI designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Objectives
On successful completion of this activity, participants should be able to describe…
1. List the basic principles of prostate cancer radiotherapy planning.
2. Review different PET/CT molecular imaging probes for prostate cancer and their applications for prostate cancer radiotherapy planning.
3. Examine the relevant recent and ongoing retrospective and prospective studies on the impact of PET/CT molecular imaging for prostate cancer radiotherapy planning.


Target Audience
This article contains information of value to physicians, in particular nuclear medicine physicians, interested in how PET/CT can be utilized in prostate cancer radiotherapy planning as well as to radiation oncologists interested in incorporating PET/CT molecular imaging into prostate cancer radiotherapy planning.

Authors
Jeremie Calais1, Minsong Cao2, and Nicholas G. Nickols2,3

1Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California; 2Department of Radiation Oncology, UCLA, Los Angeles, California; and 3Department of Radiation Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, California


Disclosure
Jeremie Calais is the recipient of a grant from the Foundation ARC pour la recherche sur le cancer (grant SAE20160604150). Nicholas Nickols is a Prostate Cancer Foundation Young Investigator and a recipient of a VA Career Development Award (5IK2BX002520), a UCLA Prostate SPORE Career Enhancement Award (4P50CA092131), a STOP Cancer Foundation Career Development Award, and a UCLA JCCC Seed Grant. In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the authors have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.

Contact Information

For questions please contact Lisa Dickinson, Associate Director of Education at ldickinson@snmmi.org or 703-652-6783.